Stock analysts at StockNews.com began coverage on shares of China Pharma (NYSE:CPHI – Get Free Report) in a research report issued on Thursday. The firm set a “hold” rating on the stock.
China Pharma Trading Down 4.0 %
NYSE CPHI opened at $0.22 on Thursday. China Pharma has a 12-month low of $0.17 and a 12-month high of $1.21. The company has a fifty day simple moving average of $0.21 and a two-hundred day simple moving average of $0.28. The company has a quick ratio of 0.24, a current ratio of 0.84 and a debt-to-equity ratio of 0.19.
China Pharma (NYSE:CPHI – Get Free Report) last released its quarterly earnings data on Wednesday, August 14th. The company reported ($0.09) earnings per share for the quarter. The business had revenue of $0.93 million during the quarter. China Pharma had a negative return on equity of 60.19% and a negative net margin of 70.47%.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Articles
- Five stocks we like better than China Pharma
- How to Invest in Biotech Stocks
- How Much Can You Make in Stocks in One Month?
- Conference Calls and Individual Investors
- This Is the Top Large-Cap Stock Insiders Are Buying
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
